Myocardial dysfunction in a patient with adult-onset Still's disease (AOSD) [5]

Clinical and Experimental Rheumatology

Volumn 22, Issue 4, 2004, Pages 506-507

  Nishimagi, E ^a   Hirata, S ^a   Kawaguchi, Yasushi ^a   Okamoto, H ^a   Hara, M ^a   Kamatani, N ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; PREDNISOLONE; THALLIUM 201;

ADULT ONSET STILL DISEASE; CASE REPORT; DISEASE COURSE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART SCINTISCANNING; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; LETTER; MYOCARDIAL DISEASE; OUTCOMES RESEARCH; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ADULT; ANTI-INFLAMMATORY AGENTS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MYOCARDIAL ISCHEMIA; PREDNISOLONE; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 4143131029     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. BYWATERS EGL: Still's disease in the adult. Ann Rheum Dis 1971; 30: 121-33.
2. YAMAGUCHI M, OHTA A, TSUNEMATSU T et al.: Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19: 424-30.
3. BANK I, MARBOE CC, REDBERG MR, JACOBS J: Myocarditis in adult Still's disease. Arthritis Rheum 1985; 28: 452-4.
4. SACHS RN, TALVARD O, LANFRANCHI J: Myocarditis in adult Still's disease. Int J Cardiol 1990; 27: 377-80.
5. UEDA T, MIZUSHIGE K, SAKAMOTO S et al.: Adult Still's disease with myocardial dysfunction induced by microangiopathy. Jpn Circ 1997; 61: 74-7.
6. KAWASHIMA M, YAMAMURA M, TANIAI M et al.: Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001; 44: 550-60.
7. KAWAGUCHI Y, TERAJIMA H, HARIGAI M, HARA M, KAMATANI N: Interleukin-18 as a novel diagnostic marker and indicator of severity in adult-onset Still's disease. Arthritis Rheum 2001; 44: 1716-8.
8. POMERANTZ BJ, REZIKOV LL, HARKEN AH, DINARELLO CA: Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1 β. Proc Natl Acad Sci USA 2001; 98: 2871-6.
9. MALLAT Z, HENRY P, FRESSONNET R et al.: Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 2002; 88: 467-9.
10. BLANKENBERG S, TIRET L, BICKEL C et al.: Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106: 24-30.